The CDKL5 gene was first associated with a rare form of neonatal onset epileptic encephalopathy in 2004 [1,2], and in the years that followed, CDKL5 deficiency disorder (CDD) was identified as a diagnostically recognizable entity [3]. This evidence concerns the gene CDKL5 and craniodiaphyseal dysplasia.